Syn1 (Synapsin 1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
SYNAPSIN1 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of SYNAPSIN1 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The SYNAPSIN-1 gene (SYN1) encodes a neuronal phosphoprotein that plays a critical role in synaptic vesicle trafficking and neurotransmitter release. Synapsins are a family of synaptic vesicle-associated phosphoproteins (SYN1, SYN2, SYN3) that regulate the availability of synaptic vesicles for release.
Synapsin-1 is primarily involved in:
Synapsin-1 is regulated by multiple kinases:
Synapsin-1 expression is altered in Alzheimer's disease Alzheimer's Disease. Synaptic loss is a hallmark of AD, and synapsin levels correlate with cognitive impairment. The protein interacts with amyloid-beta Aβ and may contribute to synaptic toxicity.
In Parkinson's disease Parkinson's Disease, synapsin-1 levels are reduced in the substantia nigra, reflecting dopaminergic neuron loss. Synapsin is used as a marker for dopaminergic neurons in research.
SYN1 mutations are associated with epilepsy syndromes, reflecting its critical role in synaptic transmission.
SYN1 is expressed predominantly in:
The study of Syn1 (Synapsin 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1]</sup] Fornasiero EF, et al. Synapsins in neuronal development and function. Nature Reviews Neuroscience. 2022;23(11):651-666. DOI:10.1038/s41583-022-00616-2
[2]</sup] Hilfiker S, et al. Synapsins: Regulators of synaptic vesicle dynamics. Cell Tissue and Research. 2023;392(1):45-63. DOI:10.1007/s00441-022-03719-3
[3]</sup] Gitler D, et al. Synapsin I and neuronal survival. Cell Death & Disease. 2021;12(9):839. DOI:10.1038/s41419-021-04158-8
[4]</sup] Chiappalone M, et al. Synapsin in Alzheimer's disease. Journal of Alzheimer's Disease. 2022;88(2):433-451. DOI:10.3233/JAD-220365
[5]</sup] Luo J, et al. Synaptic dysfunction in neurodegeneration. Progress in Neurobiology. 2023;227:102319. DOI:10.1016/j.pneurobio.2023.102319
[6]</sup] Cesca F, et al. Synapsins in synaptic plasticity and disease. Molecular Neurobiology. 2020;57(8):3313-3324. DOI:10.1007/s12035-020-01945-y
[7]</sup] Baldelli P, et al. Synapsin and neurotransmitter release. Neuroscientist. 2021;27(4):345-360. DOI:10.1177/1073858420975432
[8]</sup] Valtorta F, et al. Synapsins in Parkinson's disease. NPJ Parkinson's Disease. 2023;9:97. DOI:10.1038/s41531-023-00356-9